Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of JORNAY PM™ (methylphenidate HCI extended-release capsules) in ...

Liraglutide compared with placebo (a sham medication) likely increases the number of people who lose at least 5% of their body weight, but its impact on unwanted effects, quality of life, and major ...

KEGE Center for ADHD, a psychiatric practice specializing in evidence-based ADHD evaluation and coordinated care, has announced a series of clinical enhancements designed to improve patient access, ...

Long-time advocate, Paris Hilton, shares her personal ADHD journey from childhood to adulthood to encourage others to speak to their ...

Affordable, clinician-reviewed assessments help SBCC reach accommodation decisions sooner and keep students on track during ...

ADHD sufferers are "stressed" about their future with more than three-quarters having run out of medication, a report for ...

KEGE Center for ADHD, a trailblazing psychiatric clinic known for its lived-experience-led approach to ADHD care, has announced a major expansion across Arizona. This growth initiative includes ...

Girls and women have been excluded from this conversation for a long time. The tide finally is starting to change, but not ...

In the randomized, double-blind, pediatric and adolescent, placebo-controlled study, CTx-1301 delivered rapid onset of effect ...

Jay Glazer opened his laptop to answer an email. Twenty minutes later, he was scrolling through game footage, texting a producer and looking up a workout routine. The email? Still unsent.

Globally, about 5 percent of children and 2.5 percent of adults have ADHD. For many, the way their brains work means they ...

NYU Langone offers an Innovations in Treatment Delivery of Empirically Supported Assessment & Treatment for Challenges in ...